Skip to content

Based on my review of the provided GO-CAM model and related literature, I'll now provide a comprehensive review of gomodel:60418ffa00000327 (Xanthine catabolic process in Mouse).

Review of GO-CAM Model: 60418ffa00000327 - Xanthine catabolic process (Mouse)

Model Overview

This GO-CAM model (gomodel:60418ffa00000327) represents the xanthine catabolic process in mouse (Mus musculus, NCBI Taxon: 10090). The model depicts the pathway for the degradation of purines into allantoin, focusing on the conversion of xanthine to uric acid and its subsequent metabolism.

Pathway Structure and Model Accuracy

The model correctly represents the purine catabolism pathway in mice, showing:

  1. Initial conversion of xanthine by xanthine dehydrogenase/oxidase (Xdh) activity
  2. Oxidation of uric acid by urate oxidase (Uox)
  3. Subsequent processing by hydroxyisourate hydrolase (Urah)
  4. Final conversion to allantoin by 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (Urad)

The flow of activities follows the correct biochemical sequence as supported by the references, particularly PMID:16462750, which describes the complete uric acid degradation pathway.

Causal Connections

The model properly uses the causal relation RO:0002413 (provides input for) to connect the molecular activities, indicating that the product of one reaction serves as the substrate for the next. The causal connections accurately reflect the metabolic flow:

  • Xanthine oxidase/dehydrogenase activities (3 instances) → urate oxidase activity
  • Urate oxidase activity → hydroxyisourate hydrolase activity
  • Hydroxyisourate hydrolase activity → 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity

Cellular Locations

The model appropriately represents the cellular locations where these reactions occur: - Xanthine dehydrogenase activity is shown in both cytosol (GO:0005829) and peroxisome (GO:0005777) - Urate oxidase, hydroxyisourate hydrolase, and OHCU decarboxylase activities are all shown in peroxisome (GO:0005777)

This is accurate according to the literature, particularly the peroxisomal localization of the later steps in this pathway.

Evidence and References

The model is well-supported by primary literature: - PMID:16462750 (Ramazzina et al., 2006) is used extensively and appropriately, as it describes the complete pathway - PMID:1590774 (Terao et al., 1992) correctly supports the xanthine dehydrogenase aspects - PMID:4207016 (Lee, 1973) supports the developmental aspects of these enzymes in mice

Gene Products and Molecular Functions

The gene products and their molecular functions are correctly associated: - MGI:MGI:98973 (Xdh) with xanthine dehydrogenase (GO:0004854) and xanthine oxidase (GO:0004855) activities - MGI:MGI:98907 (Uox) with urate oxidase activity (GO:0004846) - MGI:MGI:1916142 (Urah) with hydroxyisourate hydrolase activity (GO:0033971) - MGI:MGI:3647519 (Urad) with 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase activity (GO:0051997)

Output Representation

The model correctly shows allantoin (CHEBI:15676) as the final product of this pathway, which is the output of the Urad activity.

Consistency with GO-CAM Best Practices

I've reviewed the GO-CAM complex annotation document, and this model follows the best practices:

  1. The activities are properly enabled by the relevant gene products
  2. Causal relations use the appropriate RO terms
  3. Cellular locations are accurately represented
  4. Evidence is properly cited with ECO codes and PMIDs
  5. The biological process context is correctly provided (GO:0009115 - xanthine catabolic process)

Areas for Potential Improvement

While the model is generally well-constructed, there are a few potential improvements:

  1. Completeness of pathway: The model could include the earlier steps in purine catabolism (hypoxanthine → xanthine) for a more complete representation.

  2. Substrate representation: While the model shows allantoin as the output, it could explicitly represent uric acid and other intermediates as inputs to their respective reactions.

  3. Regulatory aspects: The model doesn't capture regulatory aspects of this pathway, such as the conversion between xanthine dehydrogenase and oxidase forms, which is mentioned in the UniProt entry for Xdh.

Conclusion

The GO-CAM model gomodel:60418ffa00000327 accurately represents the xanthine catabolic pathway in mouse. It is well-structured, with appropriate causal connections, correct subcellular localizations, and strong supporting evidence. The model successfully represents the conversion of xanthine to allantoin through a series of enzymatic reactions, consistent with current biological knowledge.

This model serves as a good example of a metabolic pathway represented in GO-CAM format, with clear activity flow and proper evidence attribution. The minor suggested improvements would enhance the model but do not detract from its current accuracy and utility.